Novel mode of ISG15-mediated protection against influenza A virus and Sendai virus in mice

Journal of Virology

Volumn 89, Issue 1, 2015, Pages 337-349

  Morales, David J ^a   Monte, Kristen ^a   Sun, Lulu ^a   Struckhoff, Jessica J ^a   Agapov, Eugene ^a   Holtzman, Michael J ^a   Stappenbeck, Thaddeus S ^a   Lenschow, Deborah J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 15; INTERLEUKIN 6; RANTES; UNCLASSIFIED DRUG; CYTOKINE; G1P2 PROTEIN, MOUSE; UBIQUITIN;

ANIMAL CELL; ARTICLE; BRONCHUS MUCOSA; CELL PROLIFERATION; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; GENOTYPE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INFLUENZA A; INFLUENZA VIRUS A; LETHALITY; MALE; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; SENDAI VIRUS; SENDAI VIRUS INFECTION; VIROGENESIS; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; IMMUNOLOGY; INFLUENZA A VIRUS; KNOCKOUT MOUSE; METABOLISM; ORTHOMYXOVIRUS INFECTION; RESPIROVIRUS INFECTION; SURVIVAL; VIROLOGY;

CHIKUNGUNYA VIRUS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MUS; SENDAI VIRUS; VACCINIA VIRUS;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INFLUENZA A VIRUS; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; RESPIROVIRUS INFECTIONS; SENDAI VIRUS; SURVIVAL ANALYSIS; UBIQUITINS;

EID: 84919429658     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02110-14     Document Type: Article

References (64)

1. Biron CA. 1994. Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr Opin Immunol 6:530-538. http://dx.doi.org/10.1016/0952-7915(94)90137-6.
2. Medzhitov R, Schneider DS, Soares MP. 2012. Disease tolerance as a defense strategy. Science 335:936-941. http://dx.doi.org/10.1126/science.1214935.
3. Samuel CE. 2001. Antiviral actions of interferons. Clin Microbiol Rev 14:778-809. http://dx.doi.org/10.1128/CMR.14.4.778-809.2001.
4. Sen GC. 2001. Viruses and interferons. Annu Rev Microbiol 55:255-281. http://dx.doi.org/10.1146/annurev.micro.55.1.255.
5. Stetson DB, Medzhitov R. 2006. Type I interferons in host defense. Immunity 25:373-381. http://dx.doi.org/10.1016/j.immuni.2006.08.007.
6. Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 1:519-525. http://dx.doi.org/10.1016/j.coviro.2011.10.008.
7. Goodbourn S, Didcock L, Randall RE. 2000. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81:2341-2364. http://dx.doi.org/10.1099/vir.0.17157-0.
8. Korant BD, Blomstrom DC, Jonak GJ, Knight E, Jr. 1984. Interferoninduced proteins: purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. J Biol Chem 259:14835-14839.
9. Der SD, Zhou A, Williams BR, Silverman RH. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 95:15623-15628. http://dx.doi.org/10.1073/pnas.95.26.15623.
10. Knight E, Jr, Fahey D, Cordova B, Hillman M, Kutny R, Reich N, Blomstrom D. 1988. A 15-kDa interferon-induced protein is derived by COOH-terminal processing of a 17-kDa precursor. J Biol Chem 263: 4520-4522.
11. Loeb KR, Haas AL. 1992. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J Biol Chem 267:7806-7813.
12. Krug RM, Zhao C, Beaudenon S. 2005. Properties of the ISG15 E1 enzyme UbE1L. Methods Enzymol 398:32-40. http://dx.doi.org/10.1016/S0076-6879(05)98004-X.
13. Zhao C, Beaudenon SL, Kelley ML, Waddell MB, Yuan W, Schulman BA, Huibregtse JM, Krug RM. 2004. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc Natl Acad Sci USA 101:7578-7582. http://dx.doi.org/10.1073/pnas.0402528101.
14. Dastur A, Beaudenon S, Kelley M, Krug RM, Huibregtse JM. 2006. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem 281:4334-4338. http://dx.doi.org/10.1074/jbc.M512830200.
15. Kim KI, Giannakopoulos NV, Virgin HW, Zhang DE. 2004. Interferoninducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Mol Cell Biol 24:9592-9600. http://dx.doi.org/10.1128/MCB.24.21.9592-9600.2004.
16. Oudshoorn D, van Boheemen S, Sanchez-Aparicio MT, Rajsbaum R, Garcia-Sastre A, Versteeg GA. 2012. HERC6 is the main E3 ligase for global ISG15 conjugation in mouse cells. PLoS One 7:e29870. http://dx.doi.org/10.1371/journal.pone.0029870.
17. Ketscher L, Basters A, Prinz M, Knobeloch KP. 2012. mHERC6 is the essential ISG15 E3 ligase in the murine system. Biochem Biophys Res Commun 417:135-140. http://dx.doi.org/10.1016/j.bbrc.2011.11.071.
18. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. 2005. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad SciUSA 102:10200-10205. http://dx.doi.org/10.1073/pnas.0504754102.
19. Giannakopoulos NV, Luo JK, Papov V, Zou W, Lenschow DJ, Jacobs BS, Borden EC, Li J, Virgin HW, Zhang DE. 2005. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 336:496-506. http://dx.doi.org/10.1016/j.bbrc.2005.08.132.
20. Lenschow DJ, Giannakopoulos NV, Gunn LJ, Johnston C, O'Guin AK, Schmidt RE, Levine B, Virgin HW, IV. 2005. Identification of interferonstimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 79:13974-13983. http://dx.doi.org/10.1128/JVI.79.22.13974-13983.2005.
21. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, Garcia-Sastre A, Leib DA, Pekosz A, Knobeloch KP, Horak I, Virgin HWt. 2007. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci USA 104:1371-1376. http://dx.doi.org/10.1073/pnas.0607038104.
22. Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, Arenzana-Seisdedos F, Vanlandingham DL, Higgs S, Fontanet A, Albert ML, Lenschow DJ. 2011. ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog 7:e1002322. http://dx.doi.org/10.1371/journal.ppat.1002322.
23. Guerra S, Caceres A, Knobeloch KP, Horak I, Esteban M. 2008. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog 4:e1000096. http://dx.doi.org/10.1371/journal.ppat.1000096.
24. Lai C, Struckhoff JJ, Schneider J, Martinez-Sobrido L, Wolff T, Garcia-Sastre A, Zhang DE, Lenschow DJ. 2009. Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouseadapted and non-mouse-adapted influenza B virus infection. J Virol 83: 1147-1151. http://dx.doi.org/10.1128/JVI.00105-08.
25. Hsiang TY, Zhao C, Krug RM. 2009. Interferon-induced ISG15 conjugation inhibits influenzaAvirus gene expression and replication in human cells. J Virol 83:5971-5977. http://dx.doi.org/10.1128/JVI.01667-08.
26. Zhao C, Hsiang TY, Kuo RL, Krug RM. 2010. ISG15 conjugation system targets the viralNS1protein in influenzaAvirus-infected cells. Proc Natl Acad Sci USA 107:2253-2258. http://dx.doi.org/10.1073/pnas.0909144107.
27. Tang Y, Zhong G, Zhu L, Liu X, Shan Y, Feng H, Bu Z, Chen H, Wang C. 2010. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J Immunol 184:5777-5790. http://dx.doi.org/10.4049/jimmunol.0903588.
28. Shi HX, Yang K, Liu X, Liu XY, Wei B, Shan YF, Zhu LH, Wang C. 2010. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol 30:2424-2436. http://dx.doi.org/10.1128/MCB.01466-09.
29. Durfee LA, Lyon N, Seo K, Huibregtse JM. 2010. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell 38:722-732. http://dx.doi.org/10.1016/j.molcel.2010.05.002.
30. Okumura A, Lu G, Pitha-Rowe I, Pitha PM. 2006. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci USA 103:1440-1445. http://dx.doi.org/10.1073/pnas.0510518103.
31. Woods MW, Kelly JN, Hattlmann CJ, Tong JG, Xu LS, Coleman MD, Quest GR, Smiley JR, Barr SD. 2011. Human HERC5 restricts an early stage of HIV-1 assembly by a mechanism correlating with the ISGylation of Gag. Retrovirology 8:95. http://dx.doi.org/10.1186/1742-4690-8-95.
32. Okumura A, Pitha PM, Harty RN. 2008. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci USA 105:3974-3979. http://dx.doi.org/10.1073/pnas.0710629105.
33. Malakhova OA, Zhang DE. 2008. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J Biol Chem 283:8783-8787. http://dx.doi.org/10.1074/jbc.C800030200.
34. D'Cunha J, Knight E, Jr, Haas AL, Truitt RL, Borden EC. 1996. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci USA 93:211-215. http://dx.doi.org/10.1073/pnas.93.1.211.
35. D'Cunha J, Ramanujam S, Wagner RJ, Witt PL, Knight E, Jr, Borden EC. 1996. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol 157:4100-4108.
36. Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, Salem S, Radovanovic I, Grant AV, Adimi P, Mansouri N, Okada S, Bryant VL, Kong XF, Kreins A, Velez MM, Boisson B, Khalilzadeh S, Ozcelik U, Darazam IA, Schoggins JW, Rice CM, Al-Muhsen S, Behr M, Vogt G, Puel A, Bustamante J, Gros P, Huibregtse JM, Abel L, Boisson-Dupuis S, Casanova JL. 2012. Mycobacterial disease and impaired IFNgamma immunity in humans with inherited ISG15 deficiency. Science 337:1684-1688. http://dx.doi.org/10.1126/science.1224026.
37. Kim KI, Yan M, Malakhova O, Luo JK, Shen MF, Zou W, de la Torre JC, Zhang DE. 2006. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol Cell Biol 26:472-479. http://dx.doi.org/10.1128/MCB.26.2.472-479.2006.
38. Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch KP. 2005. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 25:6338-6345. http://dx.doi.org/10.1128/MCB.25.15.6338-6345.2005.
39. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, Hughes M, Perez DR, Donis R, Hoffmann E, Hobom G, Kawaoka Y. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 96:9345-9350. http://dx.doi.org/10.1073/pnas.96.16.9345.
40. You Y, Richer EJ, Huang T, Brody SL. 2002. Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population. Am J Physiol Lung Cell Mol Physiol 283:L1315-L1321.
41. Damjanovic D, Small CL, Jeyanathan M, McCormick S, Xing Z. 2012. Immunopathology in influenza virus infection: uncoupling the friend from foe. Clin Immunol 144:57-69. http://dx.doi.org/10.1016/j.clim.2012.05.005.
42. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. 2007. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85:85-92. http://dx.doi.org/10.1038/sj.icb.7100026.
43. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solorzano A, Van Rooijen N, Katz JM, Basler CF. 2005. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 79:14933-14944. http://dx.doi.org/10.1128/JVI.79.23.14933-14944.2005.
44. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM. 2008. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4:e1000115. http://dx.doi.org/10.1371/journal.ppat.1000115.
45. Brandes M, Klauschen F, Kuchen S, Germain RN. 2013. A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 154:197-212. http://dx.doi.org/10.1016/j.cell.2013.06.013.
46. Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, Theriault S, Suzuki H, Nishimura H, Mitamura K, Sugaya N, Usui T, Murata T, Maeda Y, Watanabe S, Suresh M, Suzuki T, Suzuki Y, Feldmann H, Kawaoka Y. 2004. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431:703-707. http://dx.doi.org/10.1038/nature02951.
47. Garcia-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE. 1998. The role of interferon in influenza virus tissue tropism. J Virol 72:8550-8558.
48. Look DC, Walter MJ, Williamson MR, Pang L, You Y, Sreshta JN, Johnson JE, Zander DS, Brody SL. 2001. Effects of paramyxoviral infection on airway epithelial cell Foxj1 expression, ciliogenesis, and mucociliary function. Am J Pathol 159:2055-2069. http://dx.doi.org/10.1016/S0002-9440(10)63057-X.
49. Buchweitz JP, Harkema JR, Kaminski NE. 2007. Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. Toxicol Pathol 35:424-435. http://dx.doi.org/10.1080/01926230701302558.
50. Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, Brown EG, Holtzman MJ, Brody SL. 2006. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol 80:7469-7480. http://dx.doi.org/10.1128/JVI.02677-05.
51. Yuan W, Krug RM. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 20:362-371. http://dx.doi.org/10.1093/emboj/20.3.362.
52. Sridharan H, Zhao C, Krug RM. 2010. Species specificity of the NS1 protein of influenza B virus: NS1 binds only human and non-human primate ubiquitin-like ISG15 proteins. J Biol Chem 285:7852-7856. http://dx.doi.org/10.1074/jbc.C109.095703.
53. Davidson S, Crotta S, McCabe TM, Wack A. 2014. Pathogenic potential of interferon αβ in acute influenza infection. Nat Commun 5:3864. http://dx.doi.org/10.1038/ncomms4864.
54. Lopez CB, Yount JS, Hermesh T, Moran TM. 2006. Sendai virus infection induces efficient adaptive immunity independently of type I interferons. J Virol 80:4538-4545. http://dx.doi.org/10.1128/JVI.80.9.4538-4545.2006.
55. Seo SU, Kwon HJ, Ko HJ, Byun YH, Seong BL, Uematsu S, Akira S, Kweon MN. 2011. Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog 7:e1001304. http://dx.doi.org/10.1371/journal.ppat.1001304.
56. Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, Belperio JA, Cheng G, Deng JC. 2009. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 119:1910-1920. http://dx.doi.org/10.1172/JCI35412.
57. Robinson TW, Cureton RJ, Heath RB. 1968. The pathogenesis of Sendai virus infection in the mouse lung. J Med Microbiol 1:89-95. http://dx.doi.org/10.1099/00222615-1-1-89.
58. Parker JC, Whiteman MD, Richter CB. 1978. Susceptibility of inbred and outbred mouse strains to Sendai virus and prevalence of infection in laboratory rodents. Infect Immun 19:123-130.
59. Jeon YJ, Choi JS, Lee JY, Yu KR, Kim SM, Ka SH, Oh KH, Kim KI, Zhang DE, Bang OS, Chung CH. 2009. ISG15 modification of filamin B negatively regulates the type I interferon-induced JNK signalling pathway. EMBO Rep 10:374-380. http://dx.doi.org/10.1038/embor.2009.23.
60. Yanguez E, Garcia-Culebras A, Frau A, Llompart C, Knobeloch KP, Gutierrez-Erlandsson S, Garcia-Sastre A, Esteban M, Nieto A, Guerra S. 2013. ISG15 regulates peritoneal macrophages functionality against viral infection. PLoS Pathog 9:e1003632. http://dx.doi.org/10.1371/journal.ppat.1003632.
61. Roulston A, Marcellus RC, Branton PE. 1999. Viruses and apoptosis. Annu Rev Microbiol 53:577-628. http://dx.doi.org/10.1146/annurev.micro.53.1.577.
62. Desai SD, Reed RE, Burks J, Wood LM, Pullikuth AK, Haas AL, Liu LF, Breslin JW, Meiners S, Sankar S. 2012. ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells. Exp Biol Med 237:38-49. http://dx.doi.org/10.1258/ebm.2011.011236.
63. Rodrigue-Gervais IG, Labbe K, Dagenais M, Dupaul-Chicoine J, Champagne C, Morizot A, Skeldon A, Brincks EL, Vidal SM, Griffith TS, Saleh M. 2014. Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival. Cell Host Microbe 15:23-35. http://dx.doi.org/10.1016/j.chom.2013.12.003.
64. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T, Kubota M, Turner D, Diamond JM, Goldrath AW, Farber DL, Collman RG, Wherry EJ, Artis D. 2011. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12:1045-1054. http://dx.doi.org/10.1038/ni.2131.